CNS Pharmaceuticals, Inc.
CNSPNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $35.40M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.90$10.54
- Volume (live)
- -
- Avg. volume (3M)
- 4.49K
CNS Pharmaceuticals (CNSP) Stock Price & Financial Analysis
CNS Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.65 - $5.00 |
|---|---|
| 52-Week High | $10.54 |
| 52-Week Low | $1.90 |
| Open | $4.98 |
| Volume (last close) | 13.30K |
| Average Volume (3M) | 4.49K |
| 50-Day MA | $5.47 |
|---|---|
| 200-Day MA | $4.64 |
| 1-Year Change | −43.73% |
| Market Cap | 35.40M |
|---|---|
| Shares Outstanding | 6.84M |
| Price to Book (P/B) | 1.95 |
| EV/EBITDA | -0.92 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
CNS Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, CNS Pharmaceuticals (CNSP) has a market capitalization of $35.40M.
As of its latest reported balance sheet, it holds $19.98M in cash and securities against $0.00 of debt, a net cash position of $19.98M.
CNS Pharmaceuticals does not currently pay a dividend.
The share price is down 43.7% over the past year. At $4.85 (the Oct 16, 2026 close) it sits within its 52-week range of $1.90 to $10.54, above its 200-day moving average of $4.64.
Frequently Asked Questions About CNS Pharmaceuticals
What is the current stock price for CNSP?
As of the Oct 16, 2026 close, CNSP stock trades at $4.85. The 52-week range is $1.90–$10.54, with a day range of $4.65–$5.00.
What is the P/E ratio for CNSP?
The P/E ratio (Price-to-Earnings) for CNSP is shown in the Key Statistics section. This valuation metric helps compare CNS Pharmaceuticals, Inc. to industry peers.
Does CNSP pay dividends?
CNS Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CNSP?
Analyst ratings and recommendations for CNSP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CNSP?
As of the Oct 16, 2026 close, CNS Pharmaceuticals's market capitalization is $33.2M, classifying it as a micro-cap company. CNS Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.